share_log
Moomoo 24/7 ·  Apr 9 16:31
IN8bio Announces Presentation Of New Preclinical Data For Gamma-Delta NsCAR-T Cell Therapy Platform At AACR 2024; Says 'Preclinical Data Supports Potential for Proprietary NsCAR Platform to Selectively Eliminate Cancer Cells While Preserving Healthy Tissue'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment